Augmented reality as a novel approach for addiction treatment: development of a smoking cessation app

Min-Jeong Yang, Karen O Brandon, Steven K Sutton, Marloes Kleinjan, Leslie E Sawyer, Thomas H Brandon, Christine Vinci, Min-Jeong Yang, Karen O Brandon, Steven K Sutton, Marloes Kleinjan, Leslie E Sawyer, Thomas H Brandon, Christine Vinci

Abstract

Objective: Augmented reality (AR) is a rapidly developing technology that has substantial potential as a novel approach for addiction treatment, including tobacco use. AR can facilitate the delivery of cue exposure therapy (CET) such that individuals can experience the treatment in their natural environments as viewed via a smartphone screen, addressing the limited generalizbility of extinction learning. Previously, our team developed a basic AR app for smoking cessation and demonstrated the necessary mechanisms for CET. Specifically, we showed that the AR smoking cues, compared to neutral cues, elicited substantial cue reactivity (i.e. increased urge) and that repeated exposure to the AR smoking cues reduced urge (i.e. extinction) in a laboratory setting. Here we report the next step in the systematic development of the AR app, in which we assessed the usability and acceptability of the app among daily smokers in their natural environments.

Method: Daily smokers (N = 23, 78.3% female, Mean Age = 43.4, Mean Cigarettes/Day = 14.9), not actively quitting, were instructed to use the AR app in locations and situations where they smoke (e.g. home, bar) at least 5 times per day over one week. The study is registered in clinicaltrials.gov (NCT04101422).

Results: Results indicated high usability and acceptability. Most of the participants (73.9%) used the AR app on at least 5 days. Participants found the AR cues realistic and well-integrated in their natural environments. The AR app was perceived as easy to use (Mean = 4.1/5) and learn (mean of 2 days to learn). Overall satisfaction with the app was also high. Secondary analyses found that 56.5% reported reduced smoking, with an average 26% reduction in cigarettes per day at follow-up.

Conclusions: These findings set the stage for a randomized controlled trial testing the AR app as an adjuvant therapy for treating tobacco dependence, with potential applicability to other substances. KEY MESSAGEThis study found that the augmented reality (AR) smartphone application that utlized cue exposure treatment for smoking cessation was perceived as easy to use and learn in the natural, day-to-day environment of daily smokers. Findings set the stage for a larger clinical trial testing the AR app as an adjuvant therapy for treating tobacco dependence, with potential applicability to other addictive behaviors.

Keywords: Cue exposure therapy; addiction; augmented reality; extinction; smartphone app; smoking; urge.

Conflict of interest statement

Thomas H. Brandon, Ph.D. is on the advisory board for Hava Health, Inc.

Figures

Figure 1.
Figure 1.
Summary of previous findings. (a). Median of each participant’s mean urge ratings in response to smoking and neutral cues presented via AR and in vivo (adapted from Brandon et al. 2020). (b) Mean urge ratings at pretest and posttest of AR cigarette cues for Extinction vs Control conditions, demonstrating extinction at posttest (adapted from Yang et al. 2022). AR: Augmented Reality.
Figure 2.
Figure 2.
Overview of the AR app. (a) Placement of AR cue within the AR app. (b) Sample AR trial from a participant’s view. (c) Seven AR cues within the AR app. AR: Augmented Reality.
Figure 3.
Figure 3.
CONSORT diagram. CPD: Ciagarettes Per Day; AR: Augemented reality.

References

    1. Surgeon General , The health consequences of smoking - 50 years of progress: executive summary. US Department of Health and Human Services; Atlanta (GA): Centers for Disease Control and Prevention (US); 2020.
    1. Mullins R, Borland R.. Do smokers want to quit? Aust N Z J Public Health. 1996;20(4):426–427.
    1. Valery L, et al. . Effectiveness of smoking cessation interventions among adults: a systematic review of reviews. Euro J Cancer Prevent. 2008;17(6):535–544.
    1. Brandon TH, Vidrine JI, Litvin EB.. Relapse and relapse prevention. Annu Rev Clin Psychol. 2007;3:257–284.
    1. Niaura RS, Rohsenow DJ, Binkoff JA, et al. . Relevance of cue reactivity to understanding alcohol and smoking relapse. J Abnorm Psychol. 1988;97(2):133–152.
    1. Childress AR, Mclellan AT, O'Brien CP.. Abstinent opiate abusers exhibit conditioned craving, conditioned withdrawal and reductions in both through extinction. Br J Addict. 1986;81(5):655–660.
    1. McLellan AT, Childress AR, Ehrman R, et al. . Extinguishing conditioned responses during opiate dependence treatment turning laboratory findings into clinical procedures. J Subst Abuse Treat. 1986;3(1):33–40.
    1. Monti PM, Rohsenow DJ, Rubonis AV, et al. . Cue exposure with coping skills treatment for male alcoholics: a preliminary investigation. J Consult Clin Psychol. 1993;61(6):1011–1019.
    1. Unrod M, Drobes DJ, Stasiewicz PR, et al. . Decline in cue-provoked craving during cue exposure therapy for smoking cessation. Nicotine Tob Res. 2014;16(3):306–315.
    1. Conklin CA, Tiffany ST.. Applying extinction research and theory to cue‐exposure addiction treatments. Addiction. 2002;97(2):155–167.
    1. Collins BN, Brandon TH.. Effects of extinction context and retrieval cues on alcohol cue reactivity among nonalcoholic drinkers. J Consult Clin Psychol. 2002;70(2):390–397.
    1. Bouton ME. A learning theory perspective on lapse, relapse, and the maintenance of behavior change. Health Psychol. 2000;19(1S):57–63.
    1. De Witte NAJ, Scheveneels S, Sels R, et al. . Augmenting exposure therapy: Mobile augmented reality for specific phobia. Front Virtual Real. 2020;1:8.
    1. Zimmer A, Wang N, Ibach MK, et al. . Effectiveness of a smartphone-based, augmented reality exposure app to reduce fear of spiders in real-life: a randomized controlled trial. J Anxiety Disord. 2021;82:102442.
    1. Vinci C, et al. . The clinical potential of augmented reality. Clin Psychol (New York). 2020;27(3):e12357.
    1. Eckert M, Volmerg JS, Friedrich CM.. Augmented reality in medicine: systematic and bibliographic review. JMIR Mhealth Uhealth. 2019;7(4):e10967.
    1. Segawa T, Baudry T, Bourla A, et al. . Virtual reality (VR) in assessment and treatment of addictive disorders: a systematic review. Front Neurosci. 2020;13:1409.
    1. Pew Research Center . Mobile fact sheet. 2021.
    1. Suso-Ribera C, Fernández-Álvarez J, García-Palacios A, et al. . Virtual reality, augmented reality, and in vivo exposure therapy: a preliminary comparison of treatment efficacy in small animal phobia. Cyberpsychol Behav Soc Netw. 2019;22(1):31–38.
    1. Brandon KO, Vinci C, Kleinjan M, et al. . Testing augmented reality for eliciting cue-provoked urges to smoke: toward moving cue-exposure into the real world. Nicotine Tob Res. 2021;23(5):861–865.
    1. Vinci C, Brandon KO, Kleinjan M, et al. . Augmented reality for smoking cessation: development and usability study. JMIR Mhealth Uhealth. 2020;8(12):e21643.
    1. Yang M-J, Brandon KO, Sutton SK, et al. . Augmented reality for extinction of cue-provoked urges to smoke: proof of concept. Psychol Addict Behav. 2022. Advance online publication
    1. Faulkner L. Beyond the five-user assumption: Benefits of increased sample sizes in usability testing. Behav Res Methods Instrum Comput. 2003;35(3):379–383.
    1. Prochaska JO, DiClemente CC, Norcross JC.. In search of how people change: applications to addictive behaviors. Am Psychol. 1992;47(9):1102–1114.
    1. Harrison R, Flood D, Duce D.. Usability of mobile applications: literature review and rationale for a new usability model. J Interact Sci. 2013;1(1):1–16.
    1. Nayebi F, Desharnais J-M, Abran A. The state of the art of mobile application usability evaluation. In: 2012 25th IEEE Canadian Conference on Electrical and Computer Engineering (CCECE). IEEE. 2012.
    1. Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerström test for cigarette dependence. Nicotine Tobacco Res. 2012;14(1):75–78.
    1. Heatherton TF, Kozlowski LT, Frecker RC, et al. . The fagerstrom test for nicotine dependence: a revision of the fagerstrom tolerance questionnaire. Br J Addict. 1991;86(9):1119–1127.
    1. Biener L, Abrams DB.. The contemplation ladder: validation of a measure of readiness to consider smoking cessation. Health Psychol. 1991;10(5):360–365.
    1. Simmons VN, Heckman BW, Ditre JW, et al. . A measure of smoking abstinence-related motivational engagement: Development and initial validation. Nicotine Tob Res. 2010;12(4):432–437.
    1. Velicer WF, Diclemente CC, Rossi JS, et al. . Relapse situations and self-efficacy: an integrative model. Addict Behav. 1990;15(3):271–283.
    1. Lewis J, Sauro J. The factor structure of the system UsabilityScale. In: Proceedings of the 1st international conference on human centered design: Held as part of HCI international. HCI International: San Diego, CA; 2009. p. 94–103.
    1. Brooke J, et al. . SUS: a “quick and dirty” usability scale, in usability evaluation in industry. Jordan P.W. editor. Taylor &; London: Francis; 1996. p. 189–194.
    1. Baus O, Bouchard S.. Moving from virtual reality exposure-based therapy to augmented reality exposure-based therapy: a review. Front Hum Neurosci. 2014;8:112.

Source: PubMed

3
订阅